Shypd.aiThe largest open index of AI tools
Recursion is a TechBio company pioneering AI-driven drug discovery to decode biology and radically improve lives. It leverages an AI-native platform to accelerate the development of new medicines.
Trending
About
Recursion is a clinical-stage TechBio company dedicated to decoding biology through AI to radically improve lives. Founded over a decade ago, Recursion utilizes its proprietary Recursion OS, an AI-native, end-to-end drug discovery and development platform. This platform integrates biology, chemistry, and clinical development into a unified intelligence system, powered by multimodal data, purpose-built AI models, and bilingual teams. Recursion aims to reduce the massive 90% failure rate of traditional drug discovery by using AI to understand cellular disruptions driving disease. The company has yielded an advanced pipeline of potential first-in-class and best-in-class treatments for conditions with high unmet need, including aggressive cancers and rare diseases, demonstrating significant improvements in speed, efficiency, and reduced costs from hit identification to IND-enabling studies.
Capabilities
Pricing & Plans
Enterprise
Not publicly disclosed. Check recursion.com for current pricing.
FAQs
Trending
Also listed in
